BAC Water 10mL
Sterile water with 0.9% benzyl alcohol, used to reconstitute lyophilised peptides.

SKU: PCUK-TESA10 • Batch: 100241
Stabilised GHRH analogue studied in growth-hormone axis research, supplied as a 10mg lyophilised vial at 96.506% HPLC purity with full COA.
Read the full description ↓Price includes GST
✓Free shipping on orders over $250 AUD
✓Australia Post tracked — Standard $12.99 / Express $18.99
✓Dispatched next business day (orders before 11PM AEST)
Sterile water with 0.9% benzyl alcohol, used to reconstitute lyophilised peptides.
A starter kit: two Retatrutide 10mg vials with BAC water, insulin needles and alcohol swabs.
A linear alpha-MSH analogue studied for its effect on melanin production.
Purity independently verified at a leading Australian university via HPLC & mass spectrometry.
Tesamorelin is a stabilised synthetic analogue of growth-hormone-releasing hormone (GHRH 1-44) modified with a trans-3-hexenoic acid group for increased stability. Supplied as a lyophilised powder at 96.506% HPLC purity with full Certificate of Analysis (COA) documentation.
Tesamorelin is made in-house at our GMP-compliant Australian facility, with unbroken chain-of-custody documentation from raw material through to dispatch. Every batch goes to an independent third-party lab for HPLC purity confirmation, mass spectrometry identity testing, LAL endotoxin screening (<1.0 EU/mg), and sterility testing before it ships.
Research has explored Tesamorelin's GHRH-receptor agonist activity and its effects on the GH/IGF-1 axis in metabolic research models. Strictly for in-vitro laboratory research only.
Tesamorelin is a stabilised GHRH analogue studied in preclinical research for its GHRH-receptor agonist activity and effects on the GH/IGF-1 axis. All use is strictly for in-vitro laboratory research only.
Our Tesamorelin 10mg is independently verified at 96.506% HPLC purity. Each batch is tested by an accredited third-party laboratory and ships with a full Certificate of Analysis (COA).
Store lyophilised at −20°C for long-term stability. Once reconstituted with bacteriostatic water, store at 2–8°C and use within 4 weeks. Avoid repeated freeze-thaw cycles.
Add bacteriostatic water (BAC water) slowly to the vial at a 1–2mL volume. Gently swirl; do not shake. Allow the powder to dissolve completely before use in research protocols.
Yes. Tesamorelin is legal to purchase in Australia for legitimate in-vitro laboratory and research purposes. It is not approved for human consumption or therapeutic use.
Tesamorelin 10mg is sold strictly for in-vitro laboratory and research purposes only. This product is not intended for human consumption, therapeutic use, cosmetic use, or veterinary application. It has not been evaluated by the Therapeutic Goods Administration (TGA) or any other regulatory body for human use. You must be 18 years of age or older to purchase. By purchasing, you confirm that you are a qualified researcher and will use this product in compliance with all applicable Australian laws and regulations.
No questions yet — be the first to ask about this product.
Recent peer-reviewed studies from PubMed related to Tesamorelin. Provided for research context — not medical advice.
Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data
Falutz J, Mamputu JC, Potvin D, et al. · The Journal of clinical endocrinology and metabolism · 2010
PMID: 20554713
Body composition, hepatic fat, metabolic, and safety outcomes of Tesamorelin, a GHRH analogue, in HIV-associated lipodystrophy: A meta-analysis of randomized controlled trials
Badran AS, Helal A, Shata KS, et al. · Obesity research & clinical practice · 2026
PMID: 41545261
Efficacy and safety of tesamorelin in people with HIV on integrase inhibitors
Russo SC, Ockene MW, Arpante AK, et al. · AIDS (London, England) · 2024
PMID: 38905488
Advances in the detection of growth hormone releasing hormone synthetic analogs
Memdouh S, Gavrilović I, Ng K, et al. · Drug testing and analysis · 2021
PMID: 34665524
Source: U.S. National Library of Medicine (PubMed). Citations are fetched live and cached; inclusion does not imply endorsement of any therapeutic use.